MENU
+Compare
VERO
Stock ticker: NASDAQ
AS OF
Oct 15, 11:04 AM (EDT)
Price
$2.37
Change
-$0.05 (-2.07%)
Capitalization
4.5M

VERO Venus Concept Forecast, Technical & Fundamental Analysis

Venus Concept Inc is a medical technology company... Show more

VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VERO with price predictions
Oct 14, 2025

VERO's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for VERO moved out of overbought territory on October 09, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VERO broke above its upper Bollinger Band on October 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on VERO as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VERO just turned positive on September 11, 2025. Looking at past instances where VERO's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

VERO moved above its 50-day moving average on October 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VERO crossed bullishly above the 50-day moving average on October 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VERO advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 80 cases where VERO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.933) is normal, around the industry mean (61.244). P/E Ratio (0.000) is within average values for comparable stocks, (37.499). VERO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.685). VERO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.036) is also within normal values, averaging (79.870).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VERO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a medical aesthetic technology company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
235 Yorkland Boulevard
Phone
+1 877 848-8430
Employees
304
Web
https://www.venusconcept.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLY39.942.07
+5.47%
Ally Financial
EAF19.820.40
+2.06%
GrafTech International Ltd
PLRX1.510.02
+1.34%
Pliant Therapeutics
NIVF1.820.01
+0.55%
NewGenIvf Group Limited
SRPT21.43-0.53
-2.41%
Sarepta Therapeutics

VERO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERO has been loosely correlated with ISRG. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VERO jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERO
1D Price
Change %
VERO100%
+3.86%
ISRG - VERO
35%
Loosely correlated
+0.15%
CRL - VERO
34%
Loosely correlated
-0.30%
ANSLY - VERO
33%
Loosely correlated
N/A
ALC - VERO
31%
Poorly correlated
+2.04%
SHC - VERO
30%
Poorly correlated
+2.04%
More

Groups containing VERO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERO
1D Price
Change %
VERO100%
+3.86%
Medical/Nursing Services
industry (220 stocks)
32%
Poorly correlated
+0.04%
Health Services
industry (430 stocks)
24%
Poorly correlated
+0.06%